Medpace Holdings ROE 2014-2024 | MEDP
Current and historical return on equity (ROE) values for Medpace Holdings (MEDP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Medpace Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $0.37B | $0.88B | 50.76% |
| 2024-06-30 | $0.34B | $0.76B | 55.15% |
| 2024-03-31 | $0.31B | $0.67B | 59.82% |
| 2023-12-31 | $0.28B | $0.56B | 64.03% |
| 2023-09-30 | $0.27B | $0.47B | 68.71% |
| 2023-06-30 | $0.27B | $0.39B | 73.00% |
| 2023-03-31 | $0.26B | $0.35B | 75.26% |
| 2022-12-31 | $0.25B | $0.39B | 60.34% |
| 2022-09-30 | $0.23B | $0.35B | 41.26% |
| 2022-06-30 | $0.21B | $0.28B | 30.52% |
| 2022-03-31 | $0.20B | $0.61B | 24.18% |
| 2021-12-31 | $0.18B | $0.95B | 20.44% |
| 2021-09-30 | $0.18B | $0.90B | 21.32% |
| 2021-06-30 | $0.17B | $0.85B | 21.03% |
| 2021-03-31 | $0.16B | $0.86B | 19.78% |
| 2020-12-31 | $0.14B | $0.81B | 18.86% |
| 2020-09-30 | $0.12B | $0.79B | 16.68% |
| 2020-06-30 | $0.11B | $0.74B | 14.89% |
| 2020-03-31 | $0.11B | $0.72B | 15.75% |
| 2019-12-31 | $0.10B | $0.73B | 14.83% |
| 2019-09-30 | $0.09B | $0.69B | 14.36% |
| 2019-06-30 | $0.09B | $0.66B | 14.32% |
| 2019-03-31 | $0.08B | $0.62B | 13.32% |
| 2018-12-31 | $0.07B | $0.59B | 13.26% |
| 2018-09-30 | $0.06B | $0.56B | 11.72% |
| 2018-06-30 | $0.05B | $0.54B | 10.07% |
| 2018-03-31 | $0.05B | $0.51B | 8.47% |
| 2017-12-31 | $0.04B | $0.50B | 6.84% |
| 2017-09-30 | $0.03B | $0.55B | 4.69% |
| 2017-06-30 | $0.02B | $0.61B | 3.76% |
| 2017-03-31 | $0.02B | $0.62B | 3.91% |
| 2016-12-31 | $0.01B | $0.61B | 4.26% |
| 2016-06-30 | $0.01B | $0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.662B | $1.886B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $92.839B | 12.14 |
| Cencora (COR) | United States | $49.468B | 18.60 |
| DiDi Global (DIDIY) | China | $22.650B | 0.00 |
| Natera (NTRA) | United States | $22.209B | 0.00 |
| ICON (ICLR) | Ireland | $16.344B | 14.56 |
| Revvity (RVTY) | United States | $15.033B | 26.11 |
| Avantor (AVTR) | United States | $14.626B | 21.93 |
| BioMerieux (BMXMF) | France | $14.203B | 0.00 |
| Viatris (VTRS) | United States | $13.523B | 4.17 |
| CochLear (CHEOY) | Australia | $12.916B | 0.00 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Doximity (DOCS) | United States | $10.767B | 63.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.135B | 0.00 |
| HealthEquity (HQY) | United States | $9.429B | 47.30 |
| Sonic Healthcare (SKHHY) | Australia | $8.657B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.266B | 15.97 |
| Bausch + Lomb (BLCO) | Canada | $6.301B | 29.31 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| BrightSpring Health Services (BTSG) | United States | $4.136B | 87.96 |
| Organon (OGN) | United States | $4.079B | 4.11 |
| Sotera Health (SHC) | United States | $3.875B | 20.73 |
| Surgery Partners (SGRY) | United States | $3.273B | 37.32 |
| Concentras Parent (CON) | United States | $2.998B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.937B | 0.00 |
| Premier (PINC) | United States | $2.191B | 11.40 |
| Ardent Health Partners (ARDT) | United States | $2.098B | 0.00 |
| PACS (PACS) | United States | $2.080B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.079B | 0.00 |
| Progyny (PGNY) | United States | $1.980B | 40.09 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Teladoc Health (TDOC) | United States | $1.782B | 0.00 |
| Agilon Health (AGL) | United States | $1.413B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.219B | 11.92 |
| CareDx (CDNA) | United States | $1.210B | 0.00 |
| Embecta (EMBC) | United States | $1.070B | 7.48 |
| AMN Healthcare Services Inc (AMN) | United States | $1.036B | 7.02 |
| Establishment Labs Holdings (ESTA) | $0.947B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.637B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| DocGo (DCGO) | United States | $0.490B | 18.46 |
| QDM (QDMI) | Hong Kong, SAR China | $0.480B | 12.56 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| Enhabit (EHAB) | United States | $0.422B | 36.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.280B | 0.00 |
| MultiPlan (MPLN) | United States | $0.267B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Nutex Health (NUTX) | United States | $0.243B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.184B | 0.00 |
| Biodesix (BDSX) | United States | $0.151B | 0.00 |
| So-Young (SY) | China | $0.105B | 17.83 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| ModivCare (MODV) | United States | $0.066B | 3.57 |
| Oncology Institute (TOI) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| OncoCyte (OCX) | United States | $0.034B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |